EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Magnesium sulfate gargle for preventing postoperative sore throat following laryngeal mask airway ventilation: a randomized, controlled, dose-finding trial

Lei Guo, Ling Ma, Shaoling Ma, Hanxiang Ma, Qiming Ma

Frontiers in Pharmacology · 10.07.2026 · 17

DOI: 10.3389/fphar.2026.1798716 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 10.07.2026. Verfasst von Lei Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Perioperative Medicine, General Hospital of Ningxia Medical University, Yinchuan, China. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Magnesium sulfate gargle is widely used as an intervention for preventing postoperative sore throat (POST) due to its analgesic effect achieved by inhibiting calcium influx mediated by peripheral NMDA receptors. This study aimed to investigate its optimal dosage following laryngeal mask airway (LMA) ventilation.

Methods

A total of 239 patients aged 18–60 years, with ASA grades I-II, who under general anesthesia with laryngeal mask airway intubation were included. Patients were randomized to gargle 30 ml of either normal saline or magnesium sulfate at 10, 20, or 30 mg/kg 10–15 min before anesthesia, with the primary outcome being the incidence of POST assessed in the PACU and at 2, 6, and 24 h postoperatively. The secondary outcomes included LMA ventilation-related parameters and adverse events.

Results

The incidence of POST under different dosages of magnesium sulfate was 31.7%, 18.3%, 11.9%, and 6.7% in the PACU; 28.3%, 15.0%, 6.8%, and 6.7% at 2 h; 23.3%, 10.0%, 3.4%, and 3.3% at 6 h; and 15.0%, 5.0%, 3.4%, and 1.7% at 24 h postoperatively. As the dosage of magnesium sulfate gargle increased, the incidence of POST decreased (PACU, P = 0.002; 2 h postoperatively, P = 0.002; 6 h postoperatively, P < 0.001; 24 h postoperatively, P = 0.012). The ED90 values of magnesium sulfate gargle for preventing POST in the PACU and at 2 h postoperatively were 22.747 mg/kg (95% CI: 16.524–37.616) and 18.828 mg/kg (95% CI: 12.847–31.396), respectively. No differences were observed in LMA ventilation-related parameters and adverse events across groups.

Conclusion

The prophylactic administration of magnesium sulfate gargle can effectively reduce the incidence of POST, with a dosage of 20 mg/kg identified as optimal.

Schlagwörter

Stichwörter der Autor:innen

garglegynecological laparoscopic surgerylaryngeal mask airwaymagnesium sulfatepostoperative sore throat

Autor:innen und Institutionen

  • Department of Anesthesiology and Perioperative Medicine, General Hospital of Ningxia Medical University, Yinchuan, China.

Zitieren

APA

Guo, L., Ma, L., Ma, S., Ma, H., & Ma, Q. (2026). Magnesium sulfate gargle for preventing postoperative sore throat following laryngeal mask airway ventilation: a randomized, controlled, dose-finding trial. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1798716

Vancouver

Guo L, Ma L, Ma S, Ma H, Ma Q. Magnesium sulfate gargle for preventing postoperative sore throat following laryngeal mask airway ventilation: a randomized, controlled, dose-finding trial. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1798716

BibTeX
@article{Guo2026,
  author = {Guo, Lei and Ma, Ling and Ma, Shaoling and Ma, Hanxiang and Ma, Qiming},
  title = {Magnesium sulfate gargle for preventing postoperative sore throat following laryngeal mask airway ventilation: a randomized, controlled, dose-finding trial},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1798716}
}
Kostenlos starten →